These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

6655 related items for PubMed ID: 2323850

  • 21. Antitumor activity of novel ailanthone derivatives in vitro and in vivo.
    Kato T, Suzumura Y, Fukushima M, Honda T, Nakanishi T, Noguchi T.
    Anticancer Res; 1988; 8(4):573-9. PubMed ID: 3178149
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Efficacy of photodynamic therapy against doxorubicin-resistant murine tumors.
    Canti G, Lattuada D, Morelli S, Nicolin A, Cubeddu R, Taroni P, Valentini G.
    Cancer Lett; 1995 Jul 13; 93(2):255-9. PubMed ID: 7621437
    [Abstract] [Full Text] [Related]

  • 24. Influence of supplemental ascorbate on the antitumor activity of 5-hydroxydopa, a purported cytotoxic metabolite.
    Pierson HF, Meadows GG.
    Cancer Lett; 1985 Nov 13; 29(2):157-68. PubMed ID: 3935310
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The antineoplastic effects of tuftsin and tuftsinyltuftsin on B16/5B melanoma and L1210 cells.
    Najjar VA, Linehan L, Konopińska D.
    Ann N Y Acad Sci; 1983 Nov 13; 419():261-7. PubMed ID: 6324637
    [Abstract] [Full Text] [Related]

  • 31. Therapeutic and diabetogenic potential of two newly synthesized nitrosoureido sugars.
    Bernacki RJ, Wilson GL, Mossman BT, Angelino N, Kanter PM, Korytnyk W.
    Cancer Res; 1985 Feb 13; 45(2):695-702. PubMed ID: 3881170
    [Abstract] [Full Text] [Related]

  • 32. Studies on the mechanism of 3-deazaguanine cytotoxicity in L1210-sensitive and -resistant cell lines.
    Singh G, Luna MK, Ardalan B.
    Cancer Chemother Pharmacol; 1988 Feb 13; 22(3):191-6. PubMed ID: 2900700
    [Abstract] [Full Text] [Related]

  • 33. Biochemical effects and therapeutic potential of tunicamycin in murine L1210 leukemia.
    Morin MJ, Bernacki RJ.
    Cancer Res; 1983 Apr 13; 43(4):1669-74. PubMed ID: 6339042
    [Abstract] [Full Text] [Related]

  • 34. Efficacy of DMP 840: a novel bis-naphthalimide cytotoxic agent with human solid tumor xenograft selectivity.
    McRipley RJ, Burns-Horwitz PE, Czerniak PM, Diamond RJ, Diamond MA, Miller JL, Page RJ, Dexter DL, Chen SF, Sun JH.
    Cancer Res; 1994 Jan 01; 54(1):159-64. PubMed ID: 8261436
    [Abstract] [Full Text] [Related]

  • 35. Methotrexate analogues. 13. Chemical and pharmacological studies on amide, hydrazide, and hydroxamic acid derivatives of the glutamate side chain.
    Rosowsky A, Yu CS, Uren J, Lazarus H, Wick M.
    J Med Chem; 1981 May 01; 24(5):559-67. PubMed ID: 6787199
    [Abstract] [Full Text] [Related]

  • 36. Differential effect of the calmodulin inhibitor trifluoperazine in modulating cellular accumulation, retention and cytotoxicity of doxorubicin in progressively doxorubicin-resistant L1210 mouse leukemia cells. Lack of correlation between cellular doxorubicin levels and expression of resistance.
    Ganapathi R, Grabowski D.
    Biochem Pharmacol; 1988 Jan 15; 37(2):185-93. PubMed ID: 3342075
    [Abstract] [Full Text] [Related]

  • 37. Comparison of antitumor effect of recombinant L-asparaginase with wild type one in vitro and in vivo.
    Guo QL, Wu MS, Chen Z.
    Acta Pharmacol Sin; 2002 Oct 15; 23(10):946-51. PubMed ID: 12370101
    [Abstract] [Full Text] [Related]

  • 38. (R,R)-2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]- bis[5-nitro-1H-benz[de]isoquinoline-1,3-(2H)-dione] dimethanesulfonate (DMP 840), a novel bis-naphthalimide with potent nonselective tumoricidal activity in vitro.
    Kirshenbaum MR, Chen SF, Behrens CH, Papp LM, Stafford MM, Sun JH, Behrens DL, Fredericks JR, Polkus ST, Sipple P.
    Cancer Res; 1994 Apr 15; 54(8):2199-206. PubMed ID: 8174127
    [Abstract] [Full Text] [Related]

  • 39. Antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugated with polyglutamic acid and its derivative.
    Kato Y, Saito M, Fukushima H, Takeda Y, Hara T.
    Cancer Res; 1984 Jan 15; 44(1):25-30. PubMed ID: 6197162
    [Abstract] [Full Text] [Related]

  • 40. Triapine (3-aminopyridine-2-carboxaldehyde- thiosemicarbazone): A potent inhibitor of ribonucleotide reductase activity with broad spectrum antitumor activity.
    Finch RA, Liu M, Grill SP, Rose WC, Loomis R, Vasquez KM, Cheng Y, Sartorelli AC.
    Biochem Pharmacol; 2000 Apr 15; 59(8):983-91. PubMed ID: 10692563
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 333.